Skip to Content

Zorvolex Approval History

FDA Approved: Yes (First approved October 18, 2013)
Brand name: Zorvolex
Generic name: diclofenac
Dosage form: Capsules
Company: Iroko Pharmaceuticals, LLC
Treatment for: Pain, Osteoarthritis

Zorvolex (diclofenac) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain, and for the management of osteoarthritis pain.

Development History and FDA Approval Process for Zorvolex

DateArticle
Aug 25, 2014Approval Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain
Oct 18, 2013Approval Iroko Pharmaceuticals Receives FDA Approval for Zorvolex

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide